Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Status:
Recruiting
Trial end date:
2023-02-15
Target enrollment:
Participant gender:
Summary
The objective is to investigate the efficacy and safety of raltitrexed-based chemotherapy
plus bevacizumab in the treatment of advanced colorectal cancer